botulinum antitoxin

From Aaushi
Jump to navigation Jump to search

Indications

  • treatment of naturally occurring noninfant botulism

Mechanism of action

Notes

  • available only from CDC

More general terms

Additional terms

References

  1. Centers for Disease Control and Prevention (CDC) Investigational Heptavalent Botulinum Antitoxin (HBAT) to Replace Licensed Botulinum Antitoxin AB and Investigational Botulinum Antitoxin E Morbidity and Mortality Weekly Report (MMWR) 2010, 59(10);299 http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5910a4.htm
  2. FDA News Release: March 22, 2013 FDA approves first Botulism Antitoxin for use in neutralizing all seven known botulinum nerve toxin serotypes. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm345128.htm
  3. 3.0 3.1 Medical Knowledge Self Assessment Program (MKSAP) 18, American College of Physicians, Philadelphia 2018
  4. CDC's botulism treatment program http://www.bt.cdc.gov/agent/botulism